Identifying Trading Partners Under the Drug Supply Chain Security Act
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 5, 2022
July 5, 2022
bf7b7d12-8a7e-47af-a970-6443dabf401e
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Nonproprietary Naming of Biological Products: Update Guidance for Industry
Guidance DocumentMarch 8, 2019Center for Drug Evaluation and Research
Identifying Trading Partners Under the Drug Supply Chain Security Act Guidance for Industry
Guidance DocumentAugust 18, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.